-The Hindu In the case of technologies with benefits and risks, it is important to have regulatory mechanisms which can help analyse them in an impartial manner It is 61 years since the beginning of new genetics based on the discovery of the double helix structure of the DNA molecule. It is also 31 years since the production of transgenic plants. The first patent for a living organism went to Dr. Anand...
More »SEARCH RESULT
Total Matching Records found : 34
Diabesity epidemic on rise in India -Sumitra Deb Roy
-The Times of India MUMBAI: Diabesity, a newly emerged term of medical science has taken more than one billion populations into its grip in past decade. Rising at an astounding level, diabesity has reached at an epidemic proportion. India is bracing for massive surge in diabesity with estimating number of sufferers in next 20 years at more than 100 million. Obesity is linked with diabetes, higher than normal body weight greatly increases...
More »Diabetes stalks rural areas too, camp finds
-The Hindu Chennai: Out of 1,550 persons screened for diabetes in a few rural pockets in the city's western suburbs, 78 persons (5 per cent) were detected with diabetes, 191 (12.3 per cent) with high blood pressure and 202 (13 per cent) with high cholesterol levels. Among the 78 diabetics - 36 men and 42 women - eight were aged between 20 and 30. Persons in the age group of 20 to 82...
More »'Food, Glorious Food'-Anuradha Sajjanhar
-The Business Standard India has to come to terms with a growing obesity problem that is rapidly becoming a crisis Obesity, an epidemic often thought to be exclusive to wealthy countries, is becoming a rapidly growing crisis for India. The National Family Health Survey of 2006 revealed that roughly one in four urban Indians was overweight or obese, and several more recent studies indicate that these numbers are increasing. A new study...
More »Paying the price-Ramya Kannan
-The Hindu The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...
More »
